CAS 52869-18-8

N1-(9,10-dioxo-9,10-dihydroanthracen-2-yl)benzamide

CAS : 52869-18-8

Formule : C₂₁H₁₃NO₃

Degré de pureté : 95%

Couleur et forme : Solid

Masse moléculaire : 327.3328

Ref: IN-DA01CAW1

SSAA09E3

CAS : 52869-18-8

SSAA09E3

Degré de pureté : ≥98%

Masse moléculaire : 327.33g/mol

Ref: 54-BUP06698

SSAA09E3

CAS : 52869-18-8

SSAA09E3 is a novel inhibitor of SARS-CoV replication, acting by preventing fusion of the viral membrane with the host cellular membrane.

Formule : C₂₁H₁₃NO₃

Degré de pureté : 99.59%

Couleur et forme : Solid

Masse moléculaire : 327.33

Ref: TM-T9293

N-(9,10-Dioxo-9,10-dihydroanthracen-2-yl)benzamide

CAS : 52869-18-8

N-(9,10-Dioxo-9,10-dihydroanthracen-2-yl)benzamide is a medicinal compound that has shown promising results in the treatment of cancer. It acts as an inhibitor of cyclin-dependent kinases (CDKs), which are proteins that regulate cell cycle progression and are often overexpressed in cancer cells. This analog has been found to induce apoptosis (cell death) in human cancer cells and shows potential as an anticancer agent. Studies have shown that it can inhibit tumor growth in mice and has a favorable safety profile. N-(9,10-Dioxo-9,10-dihydroanthracen-2-yl)benzamide is excreted primarily through urine and may offer a new avenue for developing targeted cancer therapies.

Formule : C₂₁H₁₃NO₃

Degré de pureté : Min. 95%

Masse moléculaire : 327.3 g/mol

Ref: 3D-CCA86918